TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Investigation On Behalf Of PharmaNet Development Group, Inc (NASDAQ:PDGI) Investors By A Law Firm Concerning Possible Violations Of The Federal Securities Laws Announced

  • To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

Company
PharmaNet Development Group Inc.
Security
NASDAQ: PDGI

Summary

According to a press release a law firm is currently investigating on behalf of PharmaNet Development Group, Inc (NASDAQ: PDGI) shareholders, who purchased PharmaNet Development Group, Inc common stock (NASDAQ: PDGI) between November 1, 2007 and April 30, 2008, possible violations of the federal securities laws by PharmaNet Development Group, Inc (NASDAQ: PDGI).

According to the press release the investigation focuses on allegations that the PharmaNet Development Group, Inc (NASDAQ: PDGI) knew but failed to disclose that many of its contracts with bio-technology and pharmaceutical companies were likely to be cancelled, and therefore the PharmaNet Development Group, Inc (NASDAQ: PDGI) lacked any reasonable basis for its positive statements about its future.

Start Monitoring Your Investments